These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30726989)

  • 1. Preclinical to Clinical Translation of Hemodynamic Effects in Cardiovascular Safety Pharmacology Studies.
    Bhatt S; Northcott C; Wisialowski T; Li D; Steidl-Nichols J
    Toxicol Sci; 2019 May; 169(1):272-279. PubMed ID: 30726989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical power analysis of cardiovascular safety pharmacology studies in conscious rats.
    Bhatt S; Li D; Flynn D; Wisialowski T; Hemkens M; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2016; 81():128-35. PubMed ID: 27071954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concordance between nonclinical and phase I clinical cardiovascular assessment from a cross-company data sharing initiative.
    Ewart L; Aylott M; Deurinck M; Engwall M; Gallacher DJ; Geys H; Jarvis P; Ju H; Leishman D; Leong L; McMahon N; Mead A; Milliken P; Suter W; Teisman A; Van Ammel K; Vargas HM; Wallis R; Valentin JP
    Toxicol Sci; 2014 Dec; 142(2):427-35. PubMed ID: 25246669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP).
    Kremer JJ; Bills AJ; Hanke NJ; Chen H; Meier WA; Osinski MA; Foley CM
    J Pharmacol Toxicol Methods; 2015; 75():27-37. PubMed ID: 26001324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogs.
    Regan CP; Stump GL; Detwiler TJ; Chen L; Regan HK; Gilberto DB; DeGeorge JJ; Sannajust FJ
    J Pharmacol Toxicol Methods; 2016; 81():107-14. PubMed ID: 27166580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tutorial for model-based evaluation and translation of cardiovascular safety in preclinical trials.
    Kulesh V; Vasyutin I; Volkova A; Peskov K; Kimko H; Sokolov V; Alluri R
    CPT Pharmacometrics Syst Pharmacol; 2024 Jan; 13(1):5-22. PubMed ID: 37950388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds.
    Wallman M; Borghardt JM; Martel E; Pairet N; Markert M; Jirstrand M
    J Pharmacol Toxicol Methods; 2022; 115():107171. PubMed ID: 35398273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative.
    Milliken P; Aylott M; Edmunds N; Engle S; Ewart L; Fleurance R; Guffroy M; Hargreaves A; Heinz-Taheny K; Kirk S; Leishman D; Leong L; McMahon N; Valentin JP; Watson D; Wallis R; Clements P
    Toxicol Sci; 2020 Jul; 176(1):224-235. PubMed ID: 32298455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation.
    Cheung SYA; Parkinson J; Wählby-Hamrén U; Dota CD; Kragh ÅM; Bergenholm L; Vik T; Collins T; Arfvidsson C; Pollard CE; Tomkinson HK; Hamrén B
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):365-381. PubMed ID: 29736890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery.
    't Hart BA; Laman JD; Kap YS
    Clin Pharmacol Ther; 2018 Feb; 103(2):262-270. PubMed ID: 28748631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum concentrations, hemodynamic effects, and cardiovascular lesions in dogs treated with minoxidil.
    Mesfin GM; Higgins MJ; Robinson FG; Zhong WZ
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):337-44. PubMed ID: 8887450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium.
    Guth BD; Chiang AY; Doyle J; Engwall MJ; Guillon JM; Hoffmann P; Koerner J; Mittelstadt S; Ottinger S; Pierson JB; Pugsley MK; Rossman EI; Walisser J; Sarazan RD
    J Pharmacol Toxicol Methods; 2015; 75():70-90. PubMed ID: 25843226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the utility of LVdP/dt
    Pugsley MK; Guth B; Chiang AY; Doyle JM; Engwall M; Guillon JM; Hoffmann PK; Koerner JE; Mittelstadt SW; Pierson JB; Rossman EI; Sarazan DR; Parish ST
    J Pharmacol Toxicol Methods; 2017; 85():1-21. PubMed ID: 28065821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-Informed Reverse and Forward Translation of Safety Risks in Drug Development.
    Mettetal JT
    Clin Pharmacol Ther; 2018 Feb; 103(2):199-201. PubMed ID: 29194584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium.
    Sager P; Heilbraun J; Turner JR; Gintant G; Geiger MJ; Kowey PR; Mansoor GA; Mendzelevski B; Michelson EL; Stockbridge N; Weber MA; White WB
    Am Heart J; 2013 Apr; 165(4):477-88. PubMed ID: 23537963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorespiratory safety evaluation in non-human primates.
    Ingram-Ross JL; Curran AK; Miyamoto M; Sheehan J; Thomas G; Verbeeck J; de Waal EJ; Verstynen B; Pugsley MK
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):114-24. PubMed ID: 22521338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog.
    Antic O; Koshman YE; Bird BM; Jasiek G; Wilsey AS; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2024; 126():107497. PubMed ID: 38479593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities.
    Venkatasubramanian R; Collins TA; Lesko LJ; Mettetal JT; Trame MN
    Br J Pharmacol; 2020 Aug; 177(15):3568-3590. PubMed ID: 32335903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.